Melanoma: MSLT-1--SNB is a biomarker, not a therapeutic intervention
- PMID: 24710577
- DOI: 10.1038/nrclinonc.2014.64
Melanoma: MSLT-1--SNB is a biomarker, not a therapeutic intervention
Comment in
-
MSLT-I-response of clinical trial investigators.Nat Rev Clin Oncol. 2014 Nov;11(11). doi: 10.1038/nrclinonc.2014.65-c2. Epub 2014 Oct 14. Nat Rev Clin Oncol. 2014. PMID: 25311346 No abstract available.
-
MSLT-I-response of clinical trial investigators.Nat Rev Clin Oncol. 2014 Nov;11(11). doi: 10.1038/nrclinonc.2014.65-c1. Epub 2014 Oct 14. Nat Rev Clin Oncol. 2014. PMID: 25311349 No abstract available.
Comment on
-
Final trial report of sentinel-node biopsy versus nodal observation in melanoma.N Engl J Med. 2014 Feb 13;370(7):599-609. doi: 10.1056/NEJMoa1310460. N Engl J Med. 2014. PMID: 24521106 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
